Tetsuji Suda

532 total citations
20 papers, 408 citations indexed

About

Tetsuji Suda is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tetsuji Suda has authored 20 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tetsuji Suda's work include Viral-associated cancers and disorders (3 papers), Prostate Cancer Treatment and Research (3 papers) and Genetic Syndromes and Imprinting (2 papers). Tetsuji Suda is often cited by papers focused on Viral-associated cancers and disorders (3 papers), Prostate Cancer Treatment and Research (3 papers) and Genetic Syndromes and Imprinting (2 papers). Tetsuji Suda collaborates with scholars based in Japan, United States and Switzerland. Tetsuji Suda's co-authors include Harutaka Katano, Shigeo Mori, Tetsutaro Sata, Tomoko Nakamura, M Shiota, Chihiro Kakiuchi, Aikichi Iwamoto, Natsuo Tachikawa, Georges Delsol and Mitsuo Oshimura and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Clinica Chimica Acta and Modern Pathology.

In The Last Decade

Tetsuji Suda

19 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuji Suda Japan 11 254 153 97 89 84 20 408
Karishma Bhatia India 6 228 0.9× 190 1.2× 134 1.4× 25 0.3× 19 0.2× 11 410
Nathalie Faumont France 12 218 0.9× 65 0.4× 142 1.5× 27 0.3× 27 0.3× 20 326
JM Micléa France 5 113 0.4× 284 1.9× 45 0.5× 23 0.3× 43 0.5× 6 425
Ashwini Yenamandra United States 9 107 0.4× 363 2.4× 48 0.5× 18 0.2× 16 0.2× 21 523
Saskia Gueller United States 14 80 0.3× 199 1.3× 37 0.4× 24 0.3× 9 0.1× 19 468
Ruth Zemer Israel 9 124 0.5× 132 0.9× 38 0.4× 10 0.1× 36 0.4× 18 454
Toshiya Yokozawa Japan 8 100 0.4× 281 1.8× 31 0.3× 34 0.4× 9 0.1× 17 528
Jaroslav Žák United States 10 129 0.5× 123 0.8× 19 0.2× 13 0.1× 83 1.0× 17 446
Cynthia E. Balatoni United States 6 153 0.6× 215 1.4× 64 0.7× 9 0.1× 19 0.2× 6 402

Countries citing papers authored by Tetsuji Suda

Since Specialization
Citations

This map shows the geographic impact of Tetsuji Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuji Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuji Suda more than expected).

Fields of papers citing papers by Tetsuji Suda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuji Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuji Suda. The network helps show where Tetsuji Suda may publish in the future.

Co-authorship network of co-authors of Tetsuji Suda

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuji Suda. A scholar is included among the top collaborators of Tetsuji Suda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuji Suda. Tetsuji Suda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suda, Tetsuji, Kei Tanaka, Takuma Oshiro, et al.. (2024). MUC1 expression is associated with ST3GAL2 and negatively correlated with the androgen receptor in castration-resistant prostate cancer. Glycoconjugate Journal. 41(6). 381–394.
2.
Goya, Masato, et al.. (2024). Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma. BMC Urology. 24(1). 94–94. 2 indexed citations
3.
Suda, Tetsuji, et al.. (2021). Collagen type 1A1, type 3A1, and LOXL1/4 polymorphisms as risk factors of pelvic organ prolapse. BMC Research Notes. 14(1). 15–15. 8 indexed citations
4.
Miyata, Yasuyoshi, Tsuyoshi Matsuda, Kensuke Mitsunari, et al.. (2021). Stage-specific Embryogenic Antigen-4 Expression in Castration-resistant Prostate Cancer and its Correlation With the Androgen Receptor. Anticancer Research. 41(7). 3327–3335. 1 indexed citations
5.
Miyata, Yasuyoshi, Tomohiro Matsuo, Kensuke Mitsunari, et al.. (2020). Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate Cancer. Anticancer Research. 40(10). 5567–5575. 7 indexed citations
6.
Suda, Tetsuji, et al.. (2020). Urine Lactoferrin as a Potential Biomarker Reflecting the Degree of Malignancy in Urothelial Carcinoma of the Bladder. The Tohoku Journal of Experimental Medicine. 252(3). 225–244. 5 indexed citations
7.
Nakamura, Yuichiro, Yasuyoshi Miyata, Tomohiro Matsuo, et al.. (2019). Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancer. Glycoconjugate Journal. 36(5). 409–418. 16 indexed citations
8.
Kurozumi, Sasagu, Yuri Yamaguchi, Shinichi Hayashi, et al.. (2016). Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70‐interacting protein in postmenopausal breast cancer. Cancer Medicine. 5(8). 1873–1882. 12 indexed citations
9.
Suda, Tetsuji, et al.. (2012). ER-activating ability of breast cancer stromal fibroblasts is regulated independently of alteration of TP53 and PTEN tumor suppressor genes. Biochemical and Biophysical Research Communications. 428(2). 259–263. 8 indexed citations
10.
Matsukuma, Shoichi, Mitsuyo Yoshihara, Tetsuji Suda, et al.. (2011). Differential detection of KRAS mutations in codons 12 and 13 with a modified loop-hybrid (LH) mobility shift assay using an insert-type LH-generator. Clinica Chimica Acta. 412(19-20). 1874–1878. 3 indexed citations
11.
Sugano, Nobuhiro, Tetsuji Suda, Teni Godai, et al.. (2010). MDM2 gene amplification in colorectal cancer is associated with disease progression at the primary site, but inversely correlated with distant metastasis. Genes Chromosomes and Cancer. 49(7). 620–629. 13 indexed citations
12.
13.
Morishima, Ken‐ichi, Shuichi Sakamoto, Junya Kobayashi, et al.. (2007). TopBP1 associates with NBS1 and is involved in homologous recombination repair. Biochemical and Biophysical Research Communications. 362(4). 872–879. 35 indexed citations
14.
Suda, Tetsuji, Motonobu Katoh, Masaharu Hiratsuka, et al.. (2005). Heat-regulated production and secretion of insulin from a human artificial chromosome vector. Biochemical and Biophysical Research Communications. 340(4). 1053–1061. 16 indexed citations
15.
Nakanishi, Hirofumi, Tetsuji Suda, Motonobu Katoh, et al.. (2004). Loss of imprinting of PEG1/MEST in lung cancer cell lines. Oncology Reports. 12(6). 1273–8. 43 indexed citations
16.
Suda, Tetsuji, et al.. (2003). Use of real-time RT-PCR for the detection of allelic expression of an imprinted gene. International Journal of Molecular Medicine. 12(2). 243–6. 16 indexed citations
17.
Suda, Tetsuji, Harutaka Katano, Georges Delsol, et al.. (2001). HHV‐8 infection status of AIDS‐unrelated and AIDS‐associated multicentric Castleman's disease. Pathology International. 51(9). 671–679. 94 indexed citations
18.
Katano, Harutaka, Tetsuji Suda, Yasuyuki Morishita, et al.. (2000). Human Herpesvirus 8–Associated Solid Lymphomas that Occur in AIDS Patients Take Anaplastic Large Cell Morphology. Modern Pathology. 13(1). 77–85. 70 indexed citations
19.
Katano, Harutaka, Tetsuji Suda, Tomoko Nakamura, et al.. (1999). Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma. Journal of Medical Virology. 59(3). 346–355. 41 indexed citations
20.
Fukuda, Mamoru, Hiroki Watanabe, Tetsuji Suda, & Shigeki Shimizu. (1999). [Sequential changes in hormone levels in postmenopausal breast cancer patients under long-term treatment with an aromatase inhibitor. Kanagawa AI Study Group].. PubMed. 26(14). 2201–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karishma Bhatia Breakdown of academic impact, for papers by Nathalie Faumont Breakdown of academic impact, for papers by JM Micléa Breakdown of academic impact, for papers by Ashwini Yenamandra Breakdown of academic impact, for papers by Saskia Gueller Breakdown of academic impact, for papers by Ruth Zemer Breakdown of academic impact, for papers by Toshiya Yokozawa Breakdown of academic impact, for papers by Jaroslav Žák Breakdown of academic impact, for papers by Cynthia E. Balatoni
Rankless by CCL
2026